<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36312370</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2470-1343</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>42</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>ACS omega</Title><ISOAbbreviation>ACS Omega</ISOAbbreviation></Journal><ArticleTitle>Virus-CKB 2.0: Viral-Associated Disease-Specific Chemogenomics Knowledgebase.</ArticleTitle><Pagination><StartPage>37476</StartPage><EndPage>37484</EndPage><MedlinePgn>37476-37484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsomega.2c04258</ELocationID><Abstract><AbstractText>Transmissible and infectious viruses can cause large-scale epidemics around the world. This is because the virus can constantly mutate and produce different variants and subvariants to counter existing treatments. Therefore, a variety of treatments are urgently needed to keep up with the mutation of the viruses. To facilitate the research of such treatment, we updated our Virus-CKB 1.0 to Virus-CKB 2.0, which contains 10 kinds of viruses, including enterovirus, dengue virus, hepatitis C virus, Zika virus, herpes simplex virus, <i>Andes orthohantavirus</i>, human immunodeficiency virus, Ebola virus, Lassa virus, influenza virus, coronavirus, and norovirus. To date, Virus-CKB 2.0 archived at least 65 antiviral drugs (such as remdesivir, telaprevir, acyclovir, boceprevir, and nelfinavir) in the market, 178 viral-related targets with 292 available 3D crystal or cryo-EM structures, and 3766 chemical agents reported for these target proteins. Virus-CKB 2.0 is integrated with established tools for target prediction and result visualization; these include HTDocking, TargetHunter, blood-brain barrier (BBB) predictor, Spider Plot, etc. The Virus-CKB 2.0 server is accessible at https://www.cbligand.org/g/virus-ckb. By using the established chemogenomic tools and algorithms and newly developed tools, we can screen FDA-approved drugs and chemical compounds that may bind to these proteins involved in viral-associated disease regulation. If the virus strain mutates and the vaccine loses its effect, we can still screen drugs that can be used to treat the mutated virus in a fleeting time. In some cases, we can even repurpose FDA-approved drugs through Virus-CKB 2.0.</AbstractText><CopyrightInformation>© 2022 The Authors. Published by American Chemical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Maozi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Othman</LastName><ForeName>Yasmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xiang-Qun</ForeName><Initials>XQ</Initials><Identifier Source="ORCID">0000-0002-6881-6175</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-6533-8932</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DA035778</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA052329</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Omega</MedlineTA><NlmUniqueID>101691658</NlmUniqueID><ISSNLinking>2470-1343</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36312370</ArticleId><ArticleId IdType="pmc">PMC9609052</ArticleId><ArticleId IdType="doi">10.1021/acsomega.2c04258</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patel S. V.; Jayaweera D. T.; Althoff K. N.; Eron J. J.; Radtchenko J.; Mills A.; Moyle G.; Santiago S.; Sax P. E.; Gillman J.; Mounzer K.; Elion R. A.; Huhn G. D. Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV. PLoS One 2020, 15, e022884710.1371/journal.pone.0228847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0228847</ArticleId><ArticleId IdType="pmc">PMC7018045</ArticleId><ArticleId IdType="pubmed">32053682</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D. K.; Chung R. T., Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus. In Hepatitis C Virus Protocols ;Law M., Ed. Springer New York: New York, NY, 2019; pp. 3–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30593615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.; Liu Y.; Yang Y.; Zhang P.; Zhong W.; Wang Y.; Wang Q.; Xu Y.; Li M.; Li X.; Zheng M.; Chen L.; Li H. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B 2020, 10, 766–788. 10.1016/j.apsb.2020.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.02.008</ArticleId><ArticleId IdType="pmc">PMC7102550</ArticleId><ArticleId IdType="pubmed">32292689</ArticleId></ArticleIdList></Reference><Reference><Citation>Douangamath A.; Fearon D.; Gehrtz P.; Krojer T.; Lukacik P.; Owen C. D.; Resnick E.; Strain-Damerell C.; Aimon A.; Ábrányi-Balogh P.; Brandão-Neto J.; Carbery A.; Davison G.; Dias A.; Downes T. D.; Dunnett L.; Fairhead M.; Firth J. D.; Jones S. P.; Keeley A.; Keserü G. M.; Klein H. F.; Martin M. P.; Noble M. E. M.; O’Brien P.; Powell A.; Reddi R. N.; Skyner R.; Snee M.; Waring M. J.; Wild C.; London N.; von Delft F.; Walsh M. A. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 2020, 11, 5047.10.1038/s41467-020-18709-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18709-w</ArticleId><ArticleId IdType="pmc">PMC7542442</ArticleId><ArticleId IdType="pubmed">33028810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon C. J.; Tchesnokov E. P.; Woolner E.; Perry J. K.; Feng J. Y.; Porter D. P.; Götte M. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J. Biol. Chem. 2020, 295, 6785–6797. 10.1074/jbc.RA120.013679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.013679</ArticleId><ArticleId IdType="pmc">PMC7242698</ArticleId><ArticleId IdType="pubmed">32284326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan A.; Paray B. A.; Hussain A.; Qadir F. A.; Attar F.; Aziz F. M.; Sharifi M.; Derakhshankhah H.; Rasti B.; Mehrabi M.; Shahpasand K.; Saboury A. A.; Falahati M. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J. Biomol. Struct. Dyn. 2021, 39, 3025–3033. 10.1080/07391102.2020.1754293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1754293</ArticleId><ArticleId IdType="pmc">PMC7189411</ArticleId><ArticleId IdType="pubmed">32274964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.-Y.; Osuna C. E.; Best K.; Taylor R.; Chen E.; Yoon G.; Kublin J. L.; Schalk D.; Schultz-Darken N.; Capuano S.; Safronetz D.; Luo M.; MacLennan S.; Mathis A.; Babu Y. S.; Sheridan W. P.; Perelson A. S.; Whitney J. B. A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques. Sci. Transl. Med. 2020, 12, eaau913510.1126/scitranslmed.aau9135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau9135</ArticleId><ArticleId IdType="pmc">PMC7370316</ArticleId><ArticleId IdType="pubmed">32522808</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z.; Chen M.; Liang T.; Shen M.; Chen H.; Xie X.-Q. Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research. Briefings Bioinf. 2021, 22, 882–895. 10.1093/bib/bbaa155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa155</ArticleId><ArticleId IdType="pmc">PMC7454273</ArticleId><ArticleId IdType="pubmed">32715315</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.; Liang C.; Xin L.; Ren X.; Tian L.; Ju X.; Li H.; Wang Y.; Zhao Q.; Liu H.; Cao W.; Xie X.; Zhang D.; Wang Y.; Jian Y. The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020. Eur. J. Med. Chem. 2020, 206, 11271110.1016/j.ejmech.2020.112711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112711</ArticleId><ArticleId IdType="pmc">PMC7409838</ArticleId><ArticleId IdType="pubmed">32810751</ArticleId></ArticleIdList></Reference><Reference><Citation>Littler D. R.; Gully B. S.; Colson R. N.; Rossjohn J. Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9. iScience 2020, 23, 10125810.1016/j.isci.2020.101258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101258</ArticleId><ArticleId IdType="pmc">PMC7282741</ArticleId><ArticleId IdType="pubmed">32592996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternberg A.; Naujokat C. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination. Life Sci. 2020, 257, 11805610.1016/j.lfs.2020.118056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118056</ArticleId><ArticleId IdType="pmc">PMC7336130</ArticleId><ArticleId IdType="pubmed">32645344</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera R.; Kuhn R. J. Structural proteomics of dengue virus. Curr. Opin. Microbiol. 2008, 11, 369–377. 10.1016/j.mib.2008.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2008.06.004</ArticleId><ArticleId IdType="pmc">PMC2581888</ArticleId><ArticleId IdType="pubmed">18644250</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D. M.; Fauci A. S. Dengue and Hemorrhagic FeverA Potential Threat to Public Health in the United States. JAMA 2008, 299, 214–216. 10.1001/jama.2007.31-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2007.31-a</ArticleId><ArticleId IdType="pubmed">18182605</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirohi D.; Kuhn R. J. Zika Virus Structure, Maturation, and Receptors. J. Infect. Dis. 2017, 216, S935–s944. 10.1093/infdis/jix515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix515</ArticleId><ArticleId IdType="pmc">PMC5853281</ArticleId><ArticleId IdType="pubmed">29267925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirohi D.; Chen Z.; Sun L.; Klose T.; Pierson T. C.; Rossmann M. G.; Kuhn R. J. The 3.8 Å resolution cryo-EM structure of Zika virus. Science 2016, 352, 467–470. 10.1126/science.aaf5316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf5316</ArticleId><ArticleId IdType="pmc">PMC4845755</ArticleId><ArticleId IdType="pubmed">27033547</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantoni D.; Rossman J. S. Ebolaviruses: New roles for old proteins. PLoS Negl. Trop. Dis. 2018, 12, e000634910.1371/journal.pntd.0006349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006349</ArticleId><ArticleId IdType="pmc">PMC5933699</ArticleId><ArticleId IdType="pubmed">29723187</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan W.; Kolesnikova L.; Clarke M.; Koehler A.; Noda T.; Becker S.; Briggs J. A. G. Structure and assembly of the Ebola virus nucleocapsid. Nature 2017, 551, 394–397. 10.1038/nature24490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24490</ArticleId><ArticleId IdType="pmc">PMC5714281</ArticleId><ArticleId IdType="pubmed">29144446</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee P. T. I.; Poh C. L. Development of Novel Vaccines against Enterovirus-71. Viruses 2016, 8, 1.10.3390/v8010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010001</ArticleId><ArticleId IdType="pmc">PMC4728561</ArticleId><ArticleId IdType="pubmed">26729152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E.-J.; Shin Y.-J.; Kim J.-H.; Kim T.-G.; Chang S.-Y. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 2017, 6, 4–14. 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S.; Sun Z.; Pryce R.; Parsy M. L.; Fehling S. K.; Schlie K.; Siebert C. A.; Garten W.; Bowden T. A.; Strecker T.; Huiskonen J. T. Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike. PLoS Pathog. 2016, 12, e100541810.1371/journal.ppat.1005418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005418</ArticleId><ArticleId IdType="pmc">PMC4743923</ArticleId><ArticleId IdType="pubmed">26849049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang-Huau T. L.; Feldmann H.; Rosenke K. Animal models for Lassa virus infection. Curr. Opin. Virol. 2019, 37, 112–117. 10.1016/j.coviro.2019.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2019.07.005</ArticleId><ArticleId IdType="pubmed">31442921</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziano V. R.; Wei J.; Wilen C. B. Norovirus Attachment and Entry. Viruses 2019, 11, 495.10.3390/v11060495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11060495</ArticleId><ArticleId IdType="pmc">PMC6630345</ArticleId><ArticleId IdType="pubmed">31151248</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf M.; van Beek J.; Koopmans M. P. Human norovirus transmission and evolution in a changing world. Nat. Rev. Microbiol. 2016, 14, 421–433. 10.1038/nrmicro.2016.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.48</ArticleId><ArticleId IdType="pubmed">27211790</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright A. M.; Prober C. G. Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus. Pediatr. Clin. 2004, 51, 889–908. 10.1016/j.pcl.2004.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2004.03.005</ArticleId><ArticleId IdType="pubmed">15275980</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley R. J.; Roizman B. Herpes simplex virus infections. Lancet 2001, 357, 1513–1518. 10.1016/S0140-6736(00)04638-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04638-9</ArticleId><ArticleId IdType="pubmed">11377626</ArticleId></ArticleIdList></Reference><Reference><Citation>McElwee M.; Vijayakrishnan S.; Rixon F.; Bhella D. Structure of the herpes simplex virus portal-vertex. PLoS Biol. 2018, 16, e200619110.1371/journal.pbio.2006191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2006191</ArticleId><ArticleId IdType="pmc">PMC6028144</ArticleId><ArticleId IdType="pubmed">29924793</ArticleId></ArticleIdList></Reference><Reference><Citation>Copeland A. M.; Newcomb W. W.; Brown J. C. Herpes simplex virus replication: roles of viral proteins and nucleoporins in capsid-nucleus attachment. J. Virol. 2009, 83, 1660–1668. 10.1128/JVI.01139-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01139-08</ArticleId><ArticleId IdType="pmc">PMC2643781</ArticleId><ArticleId IdType="pubmed">19073727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vera-Otarola J.; Solis L.; Lowy F.; Olguín V.; Angulo J.; Pino K.; Tischler N. D.; Otth C.; Padula P.; López-Lastra M. The Andes orthohantavirus NSs protein antagonizes the type I interferon response by inhibiting MAVS signaling. J. Virol. 2020, 94, e00454–e00420. 10.1128/JVI.00454-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00454-20</ArticleId><ArticleId IdType="pmc">PMC7307155</ArticleId><ArticleId IdType="pubmed">32321811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.; Jeliazkova N.; Chupakhin V.; Golib-Dzib J.-F.; Engkvist O.; Carlsson L.; Wegner J.; Ceulemans H.; Georgiev I.; Jeliazkov V.; Kochev N.; Ashby T. J.; Chen H. ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics. Aust. J. Chem. 2017, 9, 17.10.1186/s13321-017-0203-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-017-0203-5</ArticleId><ArticleId IdType="pmc">PMC5340785</ArticleId><ArticleId IdType="pubmed">28316655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong R.; Yang G.; Xue R.; Liu M.; Wang F.; Hu J.; Guo X.; Chang S. COVID-19 Docking Server: an interactive server for docking small molecules, peptides and antibodies against potential targets of COVID-19. Bioinformatics 2020, 5109.10.1093/bioinformatics/btaa645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa645</ArticleId><ArticleId IdType="pmc">PMC7558834</ArticleId><ArticleId IdType="pubmed">32692801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.; Park S.-J.; Park J.; Shin H.; Jang Y.-S.; Woo J.-S.; Min D.-H. Interfaces, Identification of a Direct-Acting Antiviral Agent Targeting RNA Helicase via a Graphene Oxide Nanobiosensor. ACS Appl. Mater. Interfaces 2021, 13, 25715–25726. 10.1021/acsami.1c04641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.1c04641</ArticleId><ArticleId IdType="pubmed">34036784</ArticleId></ArticleIdList></Reference><Reference><Citation>Burley S. K.; Berman H. M.; Bhikadiya C.; Bi C.; Chen L.; Di Costanzo L.; Christie C.; Dalenberg K.; Duarte J. M.; Dutta S.; Feng Z.; Ghosh S.; Goodsell D. S.; Green R. K.; Guranovic V.; Guzenko D.; Hudson B. P.; Kalro T.; Liang Y.; Lowe R.; Namkoong H.; Peisach E.; Periskova I.; Prlic A.; Randle C.; Rose A.; Rose P.; Sala R.; Sekharan M.; Shao C.; Tan L.; Tao Y. P.; Valasatava Y.; Voigt M.; Westbrook J.; Woo J.; Yang H.; Young J.; Zhuravleva M.; Zardecki C. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res. 2019, 47, D464–D474. 10.1093/nar/gky1004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1004</ArticleId><ArticleId IdType="pmc">PMC6324064</ArticleId><ArticleId IdType="pubmed">30357411</ArticleId></ArticleIdList></Reference><Reference><Citation>Apweiler R.; Bairoch A.; Wu C. H.; Barker W. C.; Boeckmann B.; Ferro S.; Gasteiger E.; Huang H.; Lopez R.; Magrane M.; Martin M. J.; Natale D. A.; O’Donovan C.; Redaschi N.; Yeh L. S. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 2004, 32, D115–D1119. 10.1093/nar/gkh131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh131</ArticleId><ArticleId IdType="pmc">PMC308865</ArticleId><ArticleId IdType="pubmed">14681372</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaulton A.; Bellis L. J.; Bento A. P.; Chambers J.; Davies M.; Hersey A.; Light Y.; McGlinchey S.; Michalovich D.; Al-Lazikani B.; Overington J. P. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012, 40, D1100–D1107. 10.1093/nar/gkr777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr777</ArticleId><ArticleId IdType="pmc">PMC3245175</ArticleId><ArticleId IdType="pubmed">21948594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.; Shi Z.; Qin C.; Tao L.; Liu X.; Xu F.; Zhang L.; Song Y.; Liu X.; Zhang J.; Han B.; Zhang P.; Chen Y. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012, 40, D1128–D1136. 10.1093/nar/gkr797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr797</ArticleId><ArticleId IdType="pmc">PMC3245130</ArticleId><ArticleId IdType="pubmed">21948793</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C.; Zhang C.; Zhu F.; Xu F.; Chen S. Y.; Zhang P.; Li Y. H.; Yang S. Y.; Wei Y. Q.; Tao L.; Chen Y. Z. Therapeutic target database update 2014: a resource for targeted therapeutics. Nucleic Acids Res. 2014, 42, D1118–D1123. 10.1093/nar/gkt1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1129</ArticleId><ArticleId IdType="pmc">PMC3964951</ArticleId><ArticleId IdType="pubmed">24265219</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.; Qin C.; Li Y. H.; Tao L.; Zhou J.; Yu C. Y.; Xu F.; Chen Z.; Zhu F.; Chen Y. Z. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information. Nucleic Acids Res. 2016, 44, D1069–D1074. 10.1093/nar/gkv1230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1230</ArticleId><ArticleId IdType="pmc">PMC4702870</ArticleId><ArticleId IdType="pubmed">26578601</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. H.; Yu C. Y.; Li X. X.; Zhang P.; Tang J.; Yang Q.; Fu T.; Zhang X.; Cui X.; Tu G.; Zhang Y.; Li S.; Yang F.; Sun Q.; Qin C.; Zeng X.; Chen Z.; Chen Y. Z.; Zhu F. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res. 2018, 46, D1121–d1127. 10.1093/nar/gkx1076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1076</ArticleId><ArticleId IdType="pmc">PMC5753365</ArticleId><ArticleId IdType="pubmed">29140520</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.; Zhang S.; Li F.; Zhou Y.; Zhang Y.; Wang Z.; Zhang R.; Zhu J.; Ren Y.; Tan Y.; Qin C.; Li Y.; Li X.; Chen Y.; Zhu F. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 2019, 48, D1031–D1041. 10.1093/nar/gkz981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz981</ArticleId><ArticleId IdType="pmc">PMC7145558</ArticleId><ArticleId IdType="pubmed">31691823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D. S.; Feunang Y. D.; Guo A. C.; Lo E. J.; Marcu A.; Grant J. R.; Sajed T.; Johnson D.; Li C.; Sayeeda; Assempour; Iynkkaran; Liu; Maciejewski; Gale; Wilson; Chin; Cummings; le; Pon; Knox; Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018, 46, D1074–D1082. 10.1093/nar/gkx1037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1037</ArticleId><ArticleId IdType="pmc">PMC5753335</ArticleId><ArticleId IdType="pubmed">29126136</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H.; Wang L.; Lv M.; Pei R.; Li P.; Pei Z.; Wang Y.; Su W.; Xie X.-Q. AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research. J. Chem. Inf. Model. 2014, 54, 1050–1060. 10.1021/ci500004h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci500004h</ArticleId><ArticleId IdType="pmc">PMC4010297</ArticleId><ArticleId IdType="pubmed">24597646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J.; Wang S.; Lin W.; Wu N.; Wang Y.; Chen M.; Xie X.-Q.; Feng Z. Computational systems pharmacology-target mapping for fentanyl-laced cocaine overdose. ACS Chem. Neurosci. 2019, 10, 3486–3499. 10.1021/acschemneuro.9b00109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00109</ArticleId><ArticleId IdType="pmc">PMC6733029</ArticleId><ArticleId IdType="pubmed">31257858</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.; Jing Y.; Wang L.; Feng Z.; Xie X.-Q. DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs. J. Chem. Inf. Model. 2019, 59, 1283–1289. 10.1021/acs.jcim.8b00623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.8b00623</ArticleId><ArticleId IdType="pmc">PMC6758544</ArticleId><ArticleId IdType="pubmed">30835466</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O.; Olson A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010, 31, 455–461. 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.; Leung K. S.; Wong M. H. In idock: A multithreaded virtual screening tool for flexible ligand docking. 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB); IEEE, 9–12 May 2012; 2012; pp. 77–84.</Citation></Reference><Reference><Citation>Chen M.; Feng Z.; Wang S.; Lin W.; Xie X.-Q. MCCS, a novel characterization method for protein–ligand complex. Briefings Bioinf. 2021, 22, bbaa23910.1093/bib/bbaa239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa239</ArticleId><ArticleId IdType="pmc">PMC8293830</ArticleId><ArticleId IdType="pubmed">33051641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.; Ma C.; Wipf P.; Liu H.; Su W.; Xie X.-Q. TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database. AAPS J. 2013, 15, 395–406. 10.1208/s12248-012-9449-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-012-9449-z</ArticleId><ArticleId IdType="pmc">PMC3675739</ArticleId><ArticleId IdType="pubmed">23292636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.; Wang L.; Feng Z.; Cheng H.; McGuire T. F.; Ding Y.; Cheng T.; Gao Y.; Xie X.-Q. StemCellCKB: An Integrated Stem Cell-Specific Chemogenomics KnowledgeBase for Target Identification and Systems-Pharmacology Research. J. Chem. Inf. Model. 2016, 56, 1995–2004. 10.1021/acs.jcim.5b00748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.5b00748</ArticleId><ArticleId IdType="pmc">PMC5323316</ArticleId><ArticleId IdType="pubmed">27643925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.; Ma S.; Feng Z.; Wang D.; Li C.; Cao Y.; Chen X.; Liu A.; Zhu Z.; Zhang J.; Zhang G.; Chai Y.; Wang L.; Xie X.-Q. Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula. Sci. Rep. 2016, 6, 33963.10.1038/srep33963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33963</ArticleId><ArticleId IdType="pmc">PMC5039409</ArticleId><ArticleId IdType="pubmed">27678063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau T. P.; Smith R. G.; Barbercheck M. E.; Mortensen D. A. J. Spider plots: a tool for participatory extension learning. J. Extension 2010, 48, 5TOT8.</Citation></Reference><Reference><Citation>O’Boyle N. M.; Banck M.; James C. A.; Morley C.; Vandermeersch T.; Hutchison G. R. Open Babel: An open chemical toolbox. Aust. J. Chem. 2011, 3, 33.10.1186/1758-2946-3-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Boyle N. M.; Banck M.; James C. A.; Morley C.; Vandermeersch T.; Hutchison G. R. Open babel. Aust. J. Chem. 2013, 3, 33–2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertl P. Molecular structure input on the web. Aust. J. Chem. 2010, 2, 1.10.1186/1758-2946-2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-2-1</ArticleId><ArticleId IdType="pmc">PMC2827360</ArticleId><ArticleId IdType="pubmed">20298528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose A. S.; Bradley A. R.; Valasatava Y.; Duarte J. M.; Prlić A.; Rose P. W. Web-based molecular graphics for large complexes. Bioinformatics 2018, 34, 3755–3758. 10.1145/2945292.2945324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2945292.2945324</ArticleId><ArticleId IdType="pmc">PMC6198858</ArticleId><ArticleId IdType="pubmed">29850778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeuzem S.; Andreone P.; Pol S.; Lawitz E.; Diago M.; Roberts S.; Focaccia R.; Younossi Z.; Foster G. R.; Horban A.; Ferenci P.; Nevens F.; Müllhaupt B.; Pockros P.; Terg R.; Shouval D.; van Hoek B.; Weiland O.; Van Heeswijk R.; De Meyer S.; Luo D.; Boogaerts G.; Polo R.; Picchio G.; Beumont M. Telaprevir for Retreatment of HCV Infection. N. Engl. J. Med. 2011, 364, 2417–2428. 10.1056/NEJMoa1013086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1013086</ArticleId><ArticleId IdType="pubmed">21696308</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik I.; Erol M.; Duzgun Z. J. M. D. In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Mol. Diversity 2022, 26, 279–292. 10.1007/s11030-021-10215-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11030-021-10215-5</ArticleId><ArticleId IdType="pmc">PMC7992164</ArticleId><ArticleId IdType="pubmed">33765239</ArticleId></ArticleIdList></Reference><Reference><Citation>Troost B.; Smit J. M. Recent advances in antiviral drug development towards dengue virus. Curr. Opin. Virol. 2020, 43, 9–21. 10.1016/j.coviro.2020.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.07.009</ArticleId><ArticleId IdType="pubmed">32795907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaptein S. J. F.; Neyts J. Towards antiviral therapies for treating dengue virus infections. Curr. Opin. Pharmacol. 2016, 30, 1–7. 10.1016/j.coph.2016.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2016.06.002</ArticleId><ArticleId IdType="pubmed">27367615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan C. Y.; Ooi E. E.. Dengue: an update on treatment options. 2015, 10 ( (12), ), 2017–2031, Future Microbiol., 10.2217/fmb.15.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.105</ArticleId><ArticleId IdType="pubmed">26594048</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo E.; Pezzullo M.; De Burghgraeve T.; Kaptein S.; Pastorino B.; Dallmeier K.; de Lamballerie X.; Neyts J.; Hanson A. M.; Frick D. N.; Bolognesi M.; Milani M. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J. Antimicrob. Chemother. 2012, 67, 1884–1894. 10.1093/jac/dks147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks147</ArticleId><ArticleId IdType="pmc">PMC3888155</ArticleId><ArticleId IdType="pubmed">22535622</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner A. Albothyl, a substance with a new mechanism of action in the treatment of gynecological diseases. Med. Klin. 1954, 49, 1998–1999.</Citation><ArticleIdList><ArticleId IdType="pubmed">13235222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D.-W.; Mao F.; Ye Y.; Li J.; Xu C.-L.; Luo X.-M.; Chen J.; Shen X. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Acta Pharmacol. Sin. 2015, 36, 1126–1136. 10.1038/aps.2015.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2015.56</ArticleId><ArticleId IdType="pmc">PMC4561973</ArticleId><ArticleId IdType="pubmed">26279156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianevski A.; Yao R.; Biza S.; Zusinaite E.; Mannik A.; Kivi G.; Planken A.; Kurg K.; Tombak E.-M.; Ustav M.; Shtaida N.; Kulesskiy E.; Jo E.; Yang J.; Lysvand H.; Løseth K.; Oksenych V.; Aas P. A.; Tenson T.; Vitkauskienė A.; Windisch M. P.; Fenstad M. H.; Nordbø S. A.; Ustav M.; Bjørås M.; Kainov D. E.. Identification and Tracking of Antiviral Drug Combinations. 2020, 12 ( (10), ), 1178, 10.3390/v12101178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12101178</ArticleId><ArticleId IdType="pmc">PMC7589631</ArticleId><ArticleId IdType="pubmed">33080984</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris T.; Stables M.; Hobbs A.; de Souza P.; Colville-Nash P.; Warner T.; Newson J.; Bellingan G.; Gilroy D. W. Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans. J. Immunol 2009, 183, 2089–2096. 10.4049/jimmunol.0900477.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0900477</ArticleId><ArticleId IdType="pubmed">19597002</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C.-L.; Lin Y.-L.; Wu B.-C.; Tsao C.-H.; Wang M.-C.; Liu C.-I.; Huang Y.-L.; Chen J.-H.; Wang J.-P.; Chen L.-K. Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation. J. Virol. 2001, 75, 7828–7839. 10.1128/JVI.75.17.7828-7839.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.17.7828-7839.2001</ArticleId><ArticleId IdType="pmc">PMC115025</ArticleId><ArticleId IdType="pubmed">11483726</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P.; Zhang L. Aspirin inhibits hepatitis C virus entry by downregulating claudin-1. J Viral Hepatitis 2016, 23, 62–64. 10.1111/jvh.12446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvh.12446</ArticleId><ArticleId IdType="pubmed">26289738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>